According to multiple epidimiological and animal model studies, coffee's active components (chlorogenic acid, cafestol and kahweol (C + K), and caffeine) provide a chemoprotective effect and reduce the incidence and progression of liver cirrhosis. As I commented in a previous post, caffeine acts as an antagonist of the adenosine receptor, thus, it blocks adenosine from binding to its receptor and initiating a signalling pathway. The final effects of the adenosine signalling pathway include drowsiness/sleepiness (that's why coffee wakes us up!) and hepatic inflammation. Inflammation of the liver induces fibrosis that in time turns into cirrhosis, a condition associated with the eventual loss of liver function.
Moreover, cell culture and murine model studies have associated chlorogenic acid with decreased levels of carcinogenesis, and C+K and caffeine intake with anti-tumorigenic effects. Some suggested methods of action include the promotion of phase 2 detoxifying enzymes and the decrease of phase 1 activating enzymes. These findings indicate that coffee might also have a protective effect against cancer.
More studies are needed to elucidate the exact mechanisms behind these protective effects and more importantly, to identify an ideal amount of coffee intake that will provide the most benefit without driving you off the walls.